Kraematon Investment Advisors Inc. Lowers Stake in Innovator IBD 50 ETF $FFTY

Kraematon Investment Advisors Inc. lessened its stake in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY) by 49.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,922 shares of the company’s stock after selling 37,050 shares during the quarter. Kraematon Investment Advisors Inc.’s holdings in Innovator IBD 50 ETF were worth $761,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Concurrent Investment Advisors LLC increased its holdings in shares of Innovator IBD 50 ETF by 11.1% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after acquiring an additional 6,321 shares during the period. KFG Wealth Management LLC purchased a new stake in shares of Innovator IBD 50 ETF during the 2nd quarter worth $201,000. WorthPointe LLC boosted its position in Innovator IBD 50 ETF by 18.3% during the second quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock valued at $1,295,000 after purchasing an additional 3,771 shares in the last quarter. Trail Ridge Investment Advisors LLC bought a new stake in Innovator IBD 50 ETF during the second quarter valued at about $210,000. Finally, Royal Bank of Canada grew its stake in Innovator IBD 50 ETF by 3,222.5% in the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after purchasing an additional 17,724 shares during the last quarter.

Innovator IBD 50 ETF Stock Performance

Shares of Innovator IBD 50 ETF stock opened at $36.28 on Friday. The company has a market capitalization of $78.00 million, a PE ratio of 30.34 and a beta of 1.45. The company has a 50-day simple moving average of $38.13 and a two-hundred day simple moving average of $38.40. Innovator IBD 50 ETF has a one year low of $31.61 and a one year high of $44.08.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.